Surgery Partners, Inc.
NASDAQ:SGRYMedical - Care Facilities
+$0.06 today
- Market cap
- $3.53B
- Beta
- 1.95
- P/E (TTM)
- -24.1
- EPS (TTM)
- -$0.59
Volume 3.24M
Average 1.36M
SGRY Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Surgery Partners, Inc.NASDAQ: SGRY
Net Receivables · Q3 FY2026 · quarter ended Sep 2026
Net receivables falls 19.2% from a year ago
Net receivables stood at $468.1M at the end of Q3 FY2026, down 19.2% from a year earlier and down 24.1% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Net receivables amounted to 6.6% of total assets at the end of Q3 FY2026, down 0.7 pp from a year earlier.
- Net receivables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -19.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 602.2M USD
- Year-over-year change
- +4.0%
- 4-year CAGR
- +8.8%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 602.2M | +4.0% |
| FY2024 | 2024-12-31 | 579.1M | +16.7% |
| FY2023 | 2023-12-31 | 496.4M | +8.8% |
| FY2022 | 2022-12-31 | 456.3M | +6.1% |
| FY2021 | 2021-12-31 | 430.2M | — |
Net Receivables vs competitors
How SGRY compares with its peers on the latest reported figures
- SGRY's Sep 2026 net receivables of $468.1M is the 6th highest of the 7 companies compared; the peer median is $2.49B.
- Its year-over-year change of -19.2% is the 6th highest of 7, against a peer median of +4.5%.
- Net receivables amounts to 6.6% of total assets for SGRY, versus a peer median of 17.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $12.28B | +17.4% | +6.9% | 20.3% | |
| Jun 2026 | $2.8B | +21.7% | +8.9% | 17.6% | |
| Jun 2026 | $2.61B | -29.5% | -9.5% | 8.5% | |
| Mar 2026 | $2.37B | -4.4% | +1.9% | 17.9% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $709.19M | -8.7% | +3.9% | 13.5% |
| Sep 2026 | $468.1M | -19.2% | +9.7% | 6.6% | |
| Mar 2026 | $339.56M | +13.4% | +77.4% | 35.5% | |
| Peer median (excluding SGRY) | $2.49B | +4.5% | +5.4% | 17.8% | |
Competitors are the stored peer set for SGRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 389.9M | 282.9M | 195.9M | 269.5M | 239.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 430.2M | 456.3M | 496.4M | 579.1M | 602.2M |
| Inventory | 61.1M | 71.4M | 75.2M | 88.4M | 96.6M |
| Other Current Assets | 39.3M | 79M | 96.5M | 146M | 170.9M |
| Total Current Assets | 946.1M | 921M | 895M | 1.12B | 1.15B |
| Property, Plant & Equipment (Net) | 953.8M | 1.16B | 1.22B | 1.38B | 1.44B |
| Goodwill | 3.91B | 4.14B | 4.33B | 5.07B | 5.19B |
| Intangible Assets | 43.7M | 42.3M | 54.8M | 45.7M | 41M |
| Long-term Investments | 88.7M | 190.3M | 184.1M | 215.4M | 234M |
| Tax Assets | 114.4M | 91.5M | 89.5M | 0 | 122.3M |
| Other Non-current Assets | 59.1M | 144.2M | 103.3M | 57.5M | 56.8M |
| Total Non-current Assets | 5.17B | 5.76B | 5.98B | 6.77B | 7.09B |
| Total Assets | 6.12B | 6.68B | 6.88B | 7.89B | 8.24B |
| Account Payables | 124.9M | 151.6M | 171.8M | 208.7M | 208.7M |
| Short-term Debt | 60.4M | 62.8M | 73.3M | 101.4M | 99.3M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 64.4M | 3.2M | 0 | 0 | 0 |
| Other Current Liabilities | 47.3M | 49.1M | 23.9M | 24.8M | 4.7M |
| Total Current Liabilities | 536.8M | 493.4M | 523M | 624.4M | 615.5M |
| Long-term Debt | 2.88B | 2.56B | 2.7B | 3.27B | 2.71B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 39.2M | 175.7M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 87M | 75.4M | 41.1M | 30.2M | 41.2M |
| Total Non-current Liabilities | 3.28B | 2.91B | 2.99B | 3.63B | 4.1B |
| Total Liabilities | 3.82B | 3.4B | 3.51B | 4.25B | 4.72B |
| Common Stock | 900K | 1.3M | 1.3M | 1.3M | 1.3M |
| Retained Earnings | (502.7M) | (557.3M) | (569.2M) | (737.3M) | (815.2M) |
| Accumulated OCI | (31.5M) | 76.2M | 57.5M | 4.8M | (13.8M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.21B | 1.28B | 1.37B | 1.85B | 1.81B |
| Total Equity | 2.3B | 3.28B | 3.36B | 3.64B | 3.53B |
| Total Debt | 3.29B | 2.93B | 3.06B | 3.7B | 4.02B |
| Net Debt | 2.9B | 2.65B | 2.87B | 3.43B | 3.78B |
Surgery Partners, Inc.
NASDAQ:SGRY
Intrinsic Alpha fair value
Locked
Current Price
$26.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.